Announcements Trials

Browse Landscape

Phase

Status

Terminated 1 Recruiting 1 Active not recruiting 1

Sponsor Class

OTHER 10 INDUSTRY 6 NIH 1 NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Interventions

Specimen Handling 18 Cyclophosphamide 17 Magnetic Resonance Spectroscopy 16 Dexamethasone 15 Cisplatin 14 Vincristine 13 Radiotherapy 13 Radiation 11 Etoposide 10 Carboplatin 10 durvalumab 9 Radiotherapy, Intensity-Modulated 9 Paclitaxel 9 Doxorubicin 8 Cytarabine 8 Temozolomide 7 Rituximab 7 Prednisone 7 Lenalidomide 7 Irinotecan 7 Gemcitabine 7 Fluorouracil 7 Docetaxel 7 Bortezomib 7 Biopsy 7 daratumumab 6 Platinum 6 Leucovorin 6 Capecitabine 6 tremelimumab 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × NETWORK × encorafenib × Clear all

NCT03235245 2025-08-01

EBIN

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2 Active not recruiting

Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡